Growth Metrics

Cannabis Suisse (CSUI) EBIAT (2016 - 2026)

Cannabis Suisse has reported EBIAT over the past 11 years, most recently at $26908.0 for Q1 2026.

  • Quarterly EBIAT fell 8.83% to $26908.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $107574.0 through Feb 2026, up 107.17% year-over-year, with the annual reading at -$456142.0 for FY2025, 61.56% up from the prior year.
  • EBIAT was $26908.0 for Q1 2026 at Cannabis Suisse, up from $22392.0 in the prior quarter.
  • Over five years, EBIAT peaked at $44367.0 in Q2 2025 and troughed at -$999085.0 in Q2 2024.
  • The 5-year median for EBIAT is -$54797.0 (2023), against an average of -$136577.2.
  • Year-over-year, EBIAT crashed 1386.38% in 2024 and then skyrocketed 342.35% in 2025.
  • A 5-year view of EBIAT shows it stood at -$30050.0 in 2022, then plummeted by 82.35% to -$54797.0 in 2023, then skyrocketed by 109.24% to $5062.0 in 2024, then skyrocketed by 342.35% to $22392.0 in 2025, then increased by 20.17% to $26908.0 in 2026.
  • Per Business Quant, the three most recent readings for CSUI's EBIAT are $26908.0 (Q1 2026), $22392.0 (Q4 2025), and $13907.0 (Q3 2025).